Drugs / racemic salbutamol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT00831376 Comparator | Jan 2009 → Apr 2012 | asthma | University of Dundee | Completed | No outcome recorded |
| Phase 4 | NCT00830882 Comparator | Jan 2009 → Jan 2010 | asthma | University of Dundee | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | racemic salbutamol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00830882 ↗ |
| Route | Inhaled | “regular therapy with inhaled racemic salbutamol [200 μg q.i.d. (four times daily)]” PMID 23829494 ↗ Jan 2014 |